Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|
Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
UUS66989HAS7NOVARTIS CAP 20/50 D | 6.38% | 0 | 64.80% | 2.75% | 2050-08-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNDNOVARTIS CAPITAL 15/45 D | 5.69% | 0 | 83.93% | 4.00% | 2045-11-20 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 D | 5.62% | 4 M | 83.00% | 3.70% | 2042-09-21 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 D | 5.58% | 2.65 M | 90.20% | 4.70% | 2054-09-18 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAH1NOVARTIS CAPITAL 14/44 D | 5.57% | 0 | 89.16% | 4.40% | 2044-05-06 | 1.85 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 D | 5.01% | 2.47 M | 94.75% | 4.20% | 2034-09-18 | 1.1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAR9NOVARTIS CAP 20/30 D | 4.77% | 0 | 88.91% | 2.20% | 2030-08-14 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 D | 4.63% | 4.17 M | 96.82% | 4.00% | 2031-09-18 | 850 M USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 D | 4.46% | 3.43 M | 97.50% | 3.80% | 2029-09-18 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXPNCNOVARTIS CAPITAL 15/25 D | 4.43% | 0 | 99.02% | 3.00% | 2025-11-20 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
UUS66989HAN8NOVARTIS CAPITAL 17/27 D | 4.25% | 0 | 97.69% | 3.10% | 2027-05-17 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 D | 4.22% | 3.14 M | 96.01% | 2.00% | 2027-02-14 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Novartis Capital Corp. |
XXS176904160NOVARTIS FIN. 18/38 D | 3.96% | 0 | 80.16% | 1.70% | 2038-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS176904119NOVARTIS FIN. 18/30 D | 3.08% | 0 | 92.06% | 1.38% | 2030-08-14 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS223599621NOVARTIS FI. 20/28 D | 2.92% | 0 | 90.60% | 0.00% | 2028-09-23 | 1.85 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS149282548NOVARTIS FIN. 16/28 D | 2.62% | 0 | 93.52% | 0.63% | 2028-09-20 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
NNOJANOVARTIS FIN. 17/27 D | 2.54% | 0 | 96.60% | 1.13% | 2027-09-30 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
XXS113472979NOVARTIS FIN. 14/26 D | 2.47% | 0 | 98.64% | 1.63% | 2026-11-09 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novartis Finance SA |
D | 1.32% | 0 | 109.68% | 1.85% | 2049-06-18 | 190 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH135325783NOVARTIS 24/40 D | 1.30% | 0 | 106.95% | 1.85% | 2040-06-18 | 280 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH27019100NOVARTIS AG 15-35 D | 1.30% | 0 | 97.79% | 1.05% | 2035-05-11 | 325 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH135325782NOVARTIS 24/34 D | 1.15% | 0 | 105.00% | 1.75% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
A3LZ2RNOVARTIS INC 2024-18.06.31 REG S | 1.04% | 0 | 103.59% | 1.65% | 2031-06-18 | 435 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
NOTCNOVARTIS AG 15-29 D | 0.96% | 0 | 98.51% | 0.63% | 2029-11-13 | 550 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
CH135325780NOVARTIS 24/27 D | 0.72% | 0 | 101.97% | 1.60% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |
NOTBNOVARTIS AG 15-25 D | 0.47% | 0 | 99.96% | 0.25% | 2025-05-13 | 500 M CHF | 5,000.00 CHF | 5,000.00 CHF | Novartis AG |